ESR1 and neoplasm: The discovery of estrogen-independent ER activity in ER mutant breast cancer is consistent with the observation that endometrial cancer patients with ER mutant tumors have lower body mass indexes than patients with ER wild-type tumors [134], indicating that excess estrogens may not play as large a role in ER mutant tumor formation.